EICHORCondition: Cancer (With or Without Metastasis) · Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Glutamine is a crucial nutrient for cancer cell growth, and its metabolism is frequently dysregulated in malignancies. 18F-FGln is a PET tracer that targets this altered glutamine metabolism. However, there are currently limited studies on the diagnostic value of 18F-FGln PET/CT in various types of cancer. Therefore, this prospective study was conducted to investigate the value of 18F-FGln PET/CT in patients with various types of malignant tumors.
This description comes directly from the study's public registry record.
Rusen Zhang · 0086-13642328295 · zhangrusen2015@163.com
HAO PENG · 0086-13544443827 · 1194171163@QQ.COM
Always discuss trial participation with your own doctor first.
| Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Guangzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07602569